| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $21.69T | $20.43T | $16.91T | $14.55T | $13.17T |
| Cost of Revenue | $17.02T | $16.02T | $13.58T | $11.57T | $10.44T |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $20.48T | $19.05T | $16.13T | $13.68T | $12.51T |
| R&D | $1.10T | $923.63B | $880.91B | $787.06B | $738.89B |
| SG&A | $2.35T | $2.11T | $1.67T | $1.33T | $1.33T |
| Operating Income | $1.21T | $1.38T | $780.77B | $871.23B | $660.21B |
| Interest Expense | $54.91B | $59.63B | $36.11B | $16.87B | $13.88B |
| Tax Expense | $414.61B | $459.79B | $162.26B | $309.49B | $218.61B |
| Net Income | $903.03B | $1.18T | $717.31B | $760.70B | $695.44B |
| EPS (basic) | 178.9300 | 225.8800 | 384.0200 | 411.0900 | 380.7500 |
| EPS (diluted) | 178.9300 | 225.8800 | – | – | – |
| Shares (diluted) | – | – | – | – | – |